Orbit SDS
Chris is the Chief Investment Officer and a Managing Partner of Syncona Investment Management Ltd. Chris is a member of the boards of three Syncona Portfolio companies, NightstaRx Limited, Freeline Therapeutics Limited and Gyroscope Therapeutics Limited.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orbit SDS
The Orbit SDS uses a flexible cannula designed to contour to the globe and access the back of the eye, targeting a subretinal location in ...